Millennium Management’s Integra LifeSciences IART Stock Holding History

Millennium Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,000	Closed	-$335K	–	7144
2021 Q4	$335K	Buy	+5,000	New	+$338K	﹤0.01%	5427
2020 Q4	–	Sell	-10,000	Closed	-$472K	–	5371
2020 Q3	$472K	Buy	+10,000	New	+$476K	﹤0.01%	3610
2020 Q2	–	Sell	-5,000	Closed	-$223K	–	4349
2020 Q1	$223K	Buy	+5,000	New	+$262K	﹤0.01%	3332

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Millennium Management's IART Position: Q2 2026 in Review

Millennium Management increased its Integra LifeSciences (IART) stake by 131% in Q2 2026, buying an estimated $11.4M and bringing the position to 1,439,747 shares worth $25.9M. The position accounts for 0.01% of the portfolio, ranked #1395.

Millennium Management first reported a position in IART in Q3 2013 and has held it in 40 quarters since. The position peaked at $59.3M in Q1 2017. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Millennium Management held 1,439,747 shares of Integra LifeSciences worth $25.9M as of Q2 2026.
Millennium Management bought 816,894 Integra LifeSciences shares in Q2 2026, an estimated $11.4M.
Integra LifeSciences made up 0.01% of Millennium Management's portfolio in Q2 2026, its #1395 holding.
Millennium Management first reported a position in Integra LifeSciences in Q3 2013 and has held it in 40 quarters since.
Millennium Management's Integra LifeSciences position peaked at $59.3M in Q1 2017.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.